A high percentage of approximately half of ESRD patients in the United States have been reported to suffer from anemia due to erythropoietin deficiency, resulting from impairment of erythropoietin synthesis by accumulated uremic toxins [33]. This evidence concerns the gene EPO and hyperinsulinemic hypoglycemia, familial, 4.